Multi-centre Phase II trial of the polyamine synthesis inhibitor SAM486A (CGP48664) in patients with metastatic melanoma

Author: Millward Michael   Joshua Anthony   Kefford Rick   Aamdal Steinar   Thomson Damien   Hersey Peter   Toner Guy   Lynch Kevin  

Publisher: Springer Publishing Company

ISSN: 0167-6997

Source: Investigational New Drugs, Vol.23, Iss.3, 2005-06, pp. : 253-256

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content